BRPI0412268A - compostos contendo um inibidor seletivo da recaptação de serotonina e antagonista de receptor 5-ht2a - Google Patents

compostos contendo um inibidor seletivo da recaptação de serotonina e antagonista de receptor 5-ht2a

Info

Publication number
BRPI0412268A
BRPI0412268A BRPI0412268-2A BRPI0412268A BRPI0412268A BR PI0412268 A BRPI0412268 A BR PI0412268A BR PI0412268 A BRPI0412268 A BR PI0412268A BR PI0412268 A BRPI0412268 A BR PI0412268A
Authority
BR
Brazil
Prior art keywords
serotonin reuptake
reuptake inhibitor
receptor antagonist
compounds containing
selective serotonin
Prior art date
Application number
BRPI0412268-2A
Other languages
English (en)
Inventor
Robert Mark Berman
Gerard Joseph Marek
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BRPI0412268A publication Critical patent/BRPI0412268A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

"COMPOSTOS CONTENDO UM INIBIDOR SELETIVO DA RECAPTAçãO DE SEROTONINA E ANTAGONISTA DE RECEPTOR 5-HT2A". Composições compreendendo um inibidor seletivo da recaptação de serotonina (ISRS), particularmente sertralina, e um inibidor seletivo para a ligação da serotonina no sítio 5HT~ 2A~. A invenção está relacionada ao uso de tais composições para o tratamento ou a prevenção de transtornos do humor incluindo transtornos de depressão e ansiedade.
BRPI0412268-2A 2003-07-03 2004-06-21 compostos contendo um inibidor seletivo da recaptação de serotonina e antagonista de receptor 5-ht2a BRPI0412268A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48495003P 2003-07-03 2003-07-03
PCT/IB2004/002116 WO2005002578A1 (en) 2003-07-03 2004-06-21 Compositions containing a serotonin selective reuptake inhibitor and a 5-ht2a receptor antagonist

Publications (1)

Publication Number Publication Date
BRPI0412268A true BRPI0412268A (pt) 2006-09-05

Family

ID=33564037

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412268-2A BRPI0412268A (pt) 2003-07-03 2004-06-21 compostos contendo um inibidor seletivo da recaptação de serotonina e antagonista de receptor 5-ht2a

Country Status (7)

Country Link
US (1) US20050070577A1 (pt)
EP (1) EP1644000A1 (pt)
JP (1) JP2007516204A (pt)
BR (1) BRPI0412268A (pt)
CA (1) CA2530483A1 (pt)
MX (1) MXPA06000077A (pt)
WO (1) WO2005002578A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5647519B2 (ja) 2007-09-13 2014-12-24 コンサート ファーマシューティカルズ インコーポレイテッド 重水素化カテコールおよびベンゾ［ｄ］［１，３］ジオキソールおよびその誘導体の合成
GB0814466D0 (en) * 2008-08-07 2008-09-10 Rosemont Pharmaceuticals Ltd Sertraline composition
JP5061062B2 (ja) 2008-08-08 2012-10-31 パナソニック株式会社 三次元形状造形物の製造方法
WO2014046544A1 (en) 2012-09-21 2014-03-27 Aapa B.V. Substituted 3-heteroaryloxy-3-(hetero)aryl-propylamines as serotonin transporter and serotonin ht2c receptor modulators
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia
CN106353496A (zh) * 2016-11-10 2017-01-25 中国兽医药品监察所 布鲁氏菌荧光偏振（fpa）检测试剂盒
CN113855784B (zh) * 2021-09-26 2025-04-15 深圳辰扬生物科技有限公司 多肽的抗抑郁、抗焦虑用途及复合体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045488A (en) * 1974-11-06 1977-08-30 Pfizer Inc. Aminophenyltetralin compounds
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5169096A (en) * 1985-07-02 1992-12-08 Merrell Dow Pharmaceuticals Inc. N-aralkyl-piperidine-methanol derivatives
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
US5597826A (en) * 1994-09-14 1997-01-28 Pfizer Inc. Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
US5844000A (en) * 1997-06-12 1998-12-01 Sanofi Propenone oxime ethers and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
MXPA06000077A (es) 2006-04-07
US20050070577A1 (en) 2005-03-31
EP1644000A1 (en) 2006-04-12
WO2005002578A1 (en) 2005-01-13
CA2530483A1 (en) 2005-01-13
JP2007516204A (ja) 2007-06-21

Similar Documents

Publication Publication Date Title
BRPI0413563A (pt) compostos e composições como inibidores de atividade do receptor de quìnase de tirosina
MEP6208A (en) The combination of a serotonin reuptake inhibitor and a 5-ht¿2c? antagonist, inverse agonist or partial agonist
BR0307429A (pt) Composto, uso do mesmo, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com receptor de histamina h3
TW200630096A (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
PT1328269E (pt) Associacao de um antagonista do receptor cb1 e de sibutramina composicoes farmaceuticas que os contem e sua utilizacao para o tratamento da obesidade
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
BRPI0410630A (pt) antagonista de nk1
MXPA04006280A (es) Compuestos espiroazaciclicos como moduladores de receptor de monoamina.
DK1506185T3 (da) Forbindelser og deres anvendelse som 5-HT-inhibitorer
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
SE0302760D0 (sv) New compounds
DE60237528D1 (de) Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative
BR0306147A (pt) Uso de um composto ou combinação de compostos tendo atividade agonìstica de receptor de dopamina-d2 parcial e atividade inibidora de reabsorção da serotonina e/ou noradrenalina, método para a preparação de uma composição, e, composição
BR0211305A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
BR0313624A (pt) Agonismo do receptor 5ht2a para tratamento da disfunção termo-regulatória
DK1456380T3 (da) SMAD7-inhibitorer til behandling af CNS-sygdomme
MXPA05013016A (es) Gaboxadol para el tratamiento de la depresion y otros trastornos afectivos.
ATE355054T1 (de) Verfahren und verbindungen zur behandlung der depression
EP1254668A3 (en) Combination of a serotonin reuptake inhibitor and a GABA-A alpha 2/3 agonist for use in anxiety and depression
BRPI0409730A (pt) tratamento da incontinência
BRPI0516749A (pt) composições e métodos para tratamento de disturbìos cognitivos
BR0316070A (pt) Composto, composição farmacêutica, uso de um composto e, método para modular mchr
BR0115301A (pt) Uso de um inibidor seletivo da recaptação de norepinefrina

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]